48-wk Open Label Phase IIIb to Evaluate Efficacy and Safety

Summary

The purpose of this study is to assess the efficacy and safety of rosuvastatin in reducing low density lipoprotein cholesterol levels to internationally recognised goals in subjects with dyslipidaemia.

Timeline

Start

2002-02

Primary completion

—

Completion

2004-11

Drugs

Indications